Kemp’s office said the $62.5 million investment will bring roughly 340 new jobs to the Peach State over the next seven years.
“As home to some of the leading universities and technical colleges in the country, Georgia produces top talent for growing fields like the life sciences industry,” Kemp said in a news release. “Boston Scientific will find well-educated, well-trained, and hardworking Georgians who are eager to support the company’s life-changing work to fill these new positions. I look forward to seeing the impact of this expansion here in Georgia and far beyond as they keep the Peach State on the cutting edge of medical science.”
Boston Scientific purchased Georgia-based EndoChoice in 2016 and already employs about 300 people in Georgia; it has 41,000 employees worldwide.
“As we expand our presence in Georgia, we remain grateful to all of our local employees whose work is already making a difference for healthcare providers and patients around the world,” said Brad Sorenson, EVP of global operations at Boston Scientific. “Our new site in Johns Creek will enable continued growth as we fulfill our mission to transform lives.”